Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2003-11-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/JAMA.290.19.2588PMID 14625336
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: The ODIN model

  2005cited by this paper
• National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003.

  2003cited by this paper
• Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

  2003cited by this paper
• Factors predicting ventilator-associated pneumonia recurrence

  2003cited by this paper
• Staphylococcus aureus resistant to vancomycin--United States, 2002.

  2002cited by this paper
• Ventilator-associated pneumonia.

  2002cited by this paper
• Completely Resistant Acinetobacter baumannii Strains

  2002cited by this paper
• Consumption of Imipenem Correlates with β-Lactam Resistance in Pseudomonas aeruginosa

  2002cited by this paper
• Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned.

  2002cited by this paper
• From the Centers for Disease Control. Staphylococcus aureus resistant to vancomycin--United States, 2002.

  2002cited by this paper
• Antibiotic Resistance in the Intensive Care Unit

  2001cited by this paper
• Experience with a clinical guideline for the treatment of ventilator-associated pneumonia

  2001cited by this paper
• Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia.

  2001influential reference
• Invasive and Noninvasive Strategies for Management of Suspected Ventilator-Associated Pneumonia

  2000cited by this paper
• Practices to Improve Antimicrobial Use at 47 US Hospitals the Status of the 1997 SHEA/IDSA Position Paper Recommendations

  2000cited by this paper
• Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription.

  2000influential reference
• The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions.

  2000cited by this paper
• National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, issued June 1999. A report from the NNIS System.

  1999cited by this paper
• Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals.

  1999cited by this paper
• Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

  1998cited by this paper
• Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: relapse or reinfection?

  1998cited by this paper
• Indications for antibiotic use in ICU patients: a one-year prospective surveillance.

  1997influential reference
• Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance Guidelines for the Prevention of Antimicrobial Resistance in Hospitals

  1997cited by this paper
• Nosocomial pneumonia and mortality among patients in intensive care units.

  1997cited by this paper
• Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995.

  1996cited by this paper
• Nosocomial pneumonia and mortality among patients in intensive care units

  1996cited by this paper
• Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership.

  1996cited by this paper
• The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure

  1996cited by this paper
• The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.

  1995cited by this paper
• Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia.

  1995cited by this paper
• Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group

  1994cited by this paper
• Bronchoscopic diagnosis of pneumonia

  1994cited by this paper
• The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

  1994cited by this paper
• Report of the American-European consensus conference on ARDS: Definitions, mechanisms, relevant outcomes and clinical trial coordination

  1994cited by this paper
• A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study.

  1993cited by this paper
• Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins

  1993cited by this paper
• METHODOLOGY FOR CLINICAL INVESTIGATION OF VENTILATOR-ASSOCIATED PNEUMONIA : EPIDEMIOLOGY AND THERAPEUTIC INTERVENTION

  1992cited by this paper
• Methodology for clinical investigation of ventilator-associated pneumonia. Epidemiology and therapeutic intervention.

  1992cited by this paper
• [Bronchoscopic diagnosis of pneumonia].

  1992cited by this paper
• The ACCP-SCCM consensus conference on sepsis and organ failure.

  1992cited by this paper
• The Crisis in Antibiotic Resistance

  1992cited by this paper
• Planning and monitoring of equivalence studies.

  1988cited by this paper
• Testing for qualitative interactions between treatment effects and patient subsets.

  1985cited by this paper
• Designs for group sequential tests.

  1984cited by this paper
• Repeated confidence intervals for group sequential clinical trials.

  1984cited by this paper
• Gram-Negative Bacteremia: I. Etiology and Ecology

  1962cited by this paper

• Comparison of short versus long treatment duration of ESBL pneumonia in critically ill patients: a retrospective cohort study.

  2026cites this paper
• Antimicrobial Stewardship Interventions in Adults with Hospital-acquired Pneumonia: A Systematic Review and Meta-Analysis.

  2026cites this paper
• Timing of Antibiotics in ICU Pneumonia: An Observational Association Between Early Treatment and Higher Mortality

  2026cites this paper
• Duration Matters: Tailoring Antibiotic Therapy for Ventilator-Associated Pneumonia

  2026cites this paper
• Effect of prophylactic antibiotics on days of antibiotic spectrum coverage in comatose post-cardiac arrest patients: a secondary analysis of PROTECT

  2026cites this paper
• Update der S3-Leitlinie: Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie

  2025cites this paper
• Short-course antibiotic strategies for ventilator-associated pneumonia

  2025cites this paper
• Duration of antibiotic therapy for pediatric ventilator‐associated pneumonia

  2025cites this paper
• Risk Factors for Recurrent Episodes of Suspected Pneumonia

  2025cites this paper
• Short-course versus long-course antibiotic treatment for ventilator-associated pneumonia: A systematic review and meta-analysis of randomized controlled trials

  2025cites this paper
• Shifting the mindset regarding adherence to antibiotic use for respiratory tract infections

  2025cites this paper
• Early plasma cytokines associated with multi-drug resistant ventilator-associated pneumonia after neurosurgery: A retrospective cohort study.

  2025cites this paper
• Ventilator-associated pneumonia: how long is long enough?

  2025cites this paper
• Antibiotic Length of Therapy: Is Shorter Better in Older Adults?

  2025cites this paper
• A consensus of European experts on the definition of ventilator-associated pneumonia recurrences obtained by the Delphi method: the RECUVAP study

  2025cites this paper
• Modeling and simulation of distribution and drug resistance of major pathogens in patients with respiratory system infections

  2025cites this paper
• Clinical trials that could change the management of severe multidrug-resistant Gram-negative infections.

  2025cites this paper
• Duration of antibiotic treatment for community-acquired pneumonia.

  2025cites this paper
• Clinical management of sepsis-associated acute respiratory distress syndrome: current evidence and future directions

  2025cites this paper
• Antibiotic De-Escalation in the Intensive Care Unit: Rationale and Potential Strategies

  2025cites this paper
• Management of Sepsis in Hospitalized Patients.

  2025cites this paper
• Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections.

  2025cites this paper
• Nosocomial and Ventilator-associated Pneumonia

  2025cites this paper
• S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025

  2025cites this paper
• The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024

  2025cites this paper
• The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024

  2025cites this paper
• The pathogenesis of ventilator-associated pneumonia: old and new mechanisms

  2025cites this paper
• Efficacy and safety of an algorithm using C-reactive protein to guide antibiotic therapy applied through a digital clinical decision support system: a study protocol for a randomised controlled clinical trial

  2025cites this paper
• Optimal antibiotic use in the intensive care unit

  2025cites this paper
• Low skeletal muscle and subcutaneous fat at admission are associated with 90-day mortality in intensive care unit patients.

  2025cites this paper
• Application of Real-Time PCR Syndromic Panel on Lower Respiratory Tract Samples: Potential Use for Antimicrobial De-Escalation

  2025cites this paper
• Major publications in the critical care pharmacotherapy literature: 2024.

  2025cites this paper
• Antibiotic therapy for severe bacterial infections

  2025cites this paper
• Antimicrobial Resistance in Gram-Negative Bacterial Pneumonia After the COVID-19 Pandemic in Northern Iran

  2025cites this paper
• Explainable machine learning for discontinuation of therapeutic antibiotics in intensive care patients.

  2025cites this paper
• Tailoring Antibiotic Duration for Respiratory Tract Infections in Primary Care: Protocol for a Pragmatic Randomized Controlled Trial Study (STORM)

  2025cites this paper
• Antibiotic Therapy Duration for Multidrug-Resistant Gram-Negative Bacterial Infections: An Evidence-Based Review

  2025cites this paper
• Early Clinical Response is Associated With a Decreased Risk of Recurrent Pseudomonas aeruginosa Ventilator-Associated Pneumonia

  2025cites this paper
• Comparative Analysis of ESBL Phenotypes and Antimicrobial Resistance in Escherichia coli Associated with Urinary Tract Infections and in Commensal Strains

  2025cites this paper
• Antibiotic duration for common bacterial infections—a systematic review

  2025cites this paper
• Ventilator-associated pneumonia biomarker evaluation (VIBE) study: protocol for a prospective, observational, case-cohort study

  2025cites this paper
• Possible reluctance to shorten antibiotic duration in Gram-negative bacteremia and limitations of mortality-based outcomes: the need to prioritize clinical-microbiologic recurrence in future trials—Insights from the “Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness” (BALANCE)

  2025cites this paper
• Evaluation of Recurrence Rates of Pseudomonas Pneumonia in Mechanically Ventilated ICU Patients Receiving ≤7 Versus >7 Days of Antibiotic Therapy

  2024cites this paper
• Evaluation of Short Versus Long Courses of Antibiotics in Critically Ill Patients With Gram-Negative Bloodstream Infections

  2024cites this paper
• A simulation study to assess the epidemiological impact of pneumonia transmission dynamics in high-risk populations

  2024cites this paper
• Perception and views about individualising antibiotic duration for respiratory tract infections when patients feel better: a qualitative study with primary care professionals

  2024cites this paper
• Infectious Pulmonary Diseases.

  2024cites this paper
• Management of Ventilator-Associated Pneumonia: Guidelines.

  2024cites this paper
• Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa

  2024cites this paper
• Antibiotic definitive treatment in ventilator associated pneumonia caused by AmpC-producing Enterobacterales in critically ill patients: a prospective multicenter observational study

  2024cites this paper
• Seven versus 14 days of antimicrobial therapy for severe multidrug-resistant Gram-negative bacterial infections in intensive care unit patients (OPTIMISE): a randomised, open-label, non-inferiority clinical trial

  2024cites this paper
• Le rôle infirmier dans les programmes de gestion des antimicrobiens en réanimation

  2024cites this paper
• Sepsis Stewardship: The Puzzle of Antibiotic Therapy in the Context of Individualization of Decision Making

  2024cites this paper
• Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial.

  2024cites this paper
• Systemic Antibiotic Prophylaxis Adjunctive to Surgical Reconstructive Peri‐Implantitis Treatment: A Retrospective Study

  2024cites this paper
• Duration of Antimicrobial Treatment in Adult Patients with Pneumonia: A Narrative Review

  2024cites this paper
• Navigating antibiotic therapy in acute cholangitis: Best practices and new insights

  2024cites this paper
• Immediate vs. culture-initiated antibiotic therapy in suspected non-severe ventilator-associated pneumonia: a before–after study (DELAVAP)

  2024cites this paper
• Discrepancy between antibiotic pack sizes and guideline recommendations: a real-world analysis based on claims data

  2024cites this paper
• Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections.

  2024cites this paper
• Cost-effectiveness of a short-course antibiotic treatment strategy for the treatment of ventilator-associated pneumonia: an economic analysis of the REGARD-VAP trial

  2024cites this paper
• Neumonía nosocomial y neumonía asociada a la ventilación mecánica

  2024cites this paper
• An investigation of broad-spectrum antibiotic-induced liver injury based on the FDA Adverse Event Reporting System and retrospective observational study

  2024cites this paper
• Duration of antibiotic therapy for multidrug resistant Pseudomonas aeruginosa pneumonia: is shorter truly better?

  2024cites this paper
• A Bibliometric Analysis of the Role and Research Trending of Bronchoalveolar Lavage in the Diagnosis and Treatment of Ventilator-Associated Pneumonia

  2024influential citation
• Ten golden rules for optimal antibiotic use in hospitals: based on the publication statement of the International Network Group of the World Antimicrobial Resistance

  2024cites this paper
• Optimising antibiotic exposure by customising the duration of treatment for respiratory tract infections based on patient needs in primary care

  2024cites this paper
• Challenging management dogma where evidence is non-existent, weak, or outdated: part II

  2024cites this paper
• Efficacy and safety of antibiotics targeting Gram-negative bacteria in nosocomial pneumonia: a systematic review and Bayesian network meta-analysis

  2024cites this paper
• Recurrent ventilator-associated pneumonia in severe Covid-19 ARDS patients requiring ECMO support

  2024cites this paper
• Short Versus Prolonged Duration of Therapy for Pseudomonas aeruginosa Bacteremia: A Systematic Review and Meta-analysis.

  2024cites this paper
• [Short antibiotic therapy in hospitalized pneumonia: A cohort study].

  2024cites this paper
• Preventing New Gram-negative Resistance Through Beta-lactam De-escalation in Hospitalized Patients With Sepsis: A Retrospective Cohort Study.

  2024cites this paper
• Infectious diseases and infection control prevention strategies in adult and pediatric population on ECMO

  2024cites this paper
• ¿Cómo podemos optimizar el abordaje diagnóstico y terapéutico de la neumonía? Recomendaciones basadas en una opinión de expertos

  2024cites this paper
• Antibiotic duration and route for treatment of adults with uncomplicated streptococcal bloodstream infections: a retrospective study in a large healthcare system

  2024cites this paper
• Key summary of German national guideline for adult patients with nosocomial pneumonia- Update 2024 Funding number at the Federal Joint Committee (G-BA): 01VSF22007

  2024cites this paper
• How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations.

  2024cites this paper
• Efficacy of Short-Course Antibiotic Therapy for Acute Cholangitis With Positive Blood Cultures: A Retrospective Study

  2024cites this paper
• When to Stop Antibiotics in the Critically Ill?

  2024influential citation
• Association of antibiotic duration and all-cause mortality in a prospective study of patients with ventilator-associated pneumonia in a tertiary-level critical care unit in Southern India

  2024cites this paper
• Actualités sur les durées de traitement et la désescalade antibiotique en infectiologie urinaire

  2024cites this paper
• Pathogenesis, Diagnosis and Therapeutic Strategies for Ventilator-associated Pneumonia

  2024cites this paper
• Wild-Type AmpC Beta-Lactamase-Producing Enterobacterales Are a Risk Factor for Empirical Treatment Failure in Patients with Bloodstream Infection

  2024cites this paper
• Korean Guidelines for the Management and Antibiotic Therapy in Adult Patients with Hospital-Acquired Pneumonia

  2024cites this paper
• Defining the Optimal Duration of Therapy for Hospitalized Patients with Complicated Urinary Tract Infections and Associated Bacteremia.

  2023cites this paper
• The effect of duration of antimicrobial treatment for bacteremia in critically ill patients on in-hospital mortality - Retrospective double center analysis.

  2023cites this paper
• Short treatment duration for community-acquired pneumonia

  2023cites this paper
• A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol

  2023cites this paper
• Impact of reduced antibiotic treatment duration on antimicrobial resistance in critically ill patients in the randomized controlled SAPS-trial

  2023cites this paper
• Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action

  2023cites this paper
• Association of short-course antimicrobial therapy and bacterial resistance in acute cholangitis: Retrospective cohort study

  2023cites this paper
• Using natural language processing and patient journey clustering for temporal phenotyping of antimicrobial therapies for cat bite abscesses.

  2023cites this paper
• Comparison of Morbidity, Mortality, and Costs of VAP Patients with Non-VAP Patients in the Tertiary Referral Hospital of Kerman, Iran

  2023cites this paper
• Variation in knowledge, attitude, and practices toward antibiotic use among diplomates of the American Veterinary Dental College: a survey-based study.

  2023cites this paper
• Evaluating antibiotic therapy for ventilator-associated pneumonia caused by gram-negative bacilli

  2023influential citation
• A stochastic model of antibiotic misuse, economy, and drug resistance: relating mutant extinction probability to socioeconomic and epidemiological factors

  2023cites this paper
• Management of Sepsis and Septic Shock: What Have We Learned in the Last Two Decades?

  2023cites this paper
• Major Publications in the Critical Care Pharmacotherapy Literature: 2022

  2023cites this paper
• Antibiotic Therapy Strategies for Treating Gram-Negative Severe Infections in the Critically Ill: A Narrative Review

  2023cites this paper